This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prostaglandin E2

Authoring team

Prostaglandin E2 has effects including:

  • oxytocic action, although weaker than prostaglandin F2 alpha
  • bronchodilator
  • along with PGE1, maintain ductus arteriosus patency in the newborn as a result of its general vasodilatory action
  • promotes renal natriuresis and diuresis
  • gastric inhibition of acid secretion and increase in mucous secretion
  • positively inotropic on sinoatrial node
  • increase motility and secretions in gastrointestinal tract
  • hypothalamic pyretic
  • endocrine actions:
    • GH, ACTH, LH, TSH release from pituitary
    • insulin release from pancreas
    • steroid release from adrenal cortex

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.